Acorn Financial Advisory Services’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-1,748
| Closed | -$224K | – | 202 |
|
2025
Q1 | $224K | Hold |
1,748
| – | – | 0.04% | 173 |
|
2024
Q4 | $231K | Sell |
1,748
-861
| -33% | -$114K | 0.04% | 184 |
|
2024
Q3 | $380K | Hold |
2,609
| – | – | 0.07% | 134 |
|
2024
Q2 | $358K | Hold |
2,609
| – | – | 0.07% | 134 |
|
2024
Q1 | $358K | Hold |
2,609
| – | – | 0.07% | 136 |
|
2023
Q4 | $355K | Hold |
2,609
| – | – | 0.06% | 182 |
|
2023
Q3 | $319K | Hold |
2,609
| – | – | 0.06% | 185 |
|
2023
Q2 | $331K | Buy |
2,609
+23
| +0.9% | +$2.92K | 0.06% | 182 |
|
2023
Q1 | $334K | Hold |
2,586
| – | – | 0.07% | 167 |
|
2022
Q4 | $340K | Sell |
2,586
-390
| -13% | -$51.2K | 0.07% | 163 |
|
2022
Q3 | $347K | Sell |
2,976
-255
| -8% | -$29.7K | 0.08% | 155 |
|
2022
Q2 | $379K | Hold |
3,231
| – | – | 0.09% | 142 |
|
2022
Q1 | $421K | Hold |
3,231
| – | – | 0.08% | 149 |
|
2021
Q4 | $494K | Hold |
3,231
| – | – | 0.1% | 136 |
|
2021
Q3 | $523K | Buy |
3,231
+75
| +2% | +$12.1K | 0.16% | 129 |
|
2021
Q2 | $515K | Sell |
3,156
-396
| -11% | -$64.6K | 0.15% | 144 |
|
2021
Q1 | $531K | Sell |
3,552
-53
| -1% | -$7.92K | 0.19% | 120 |
|
2020
Q4 | $545K | Hold |
3,605
| – | – | 0.21% | 120 |
|
2020
Q3 | $487K | Sell |
3,605
-123
| -3% | -$16.6K | 0.26% | 109 |
|
2020
Q2 | $508K | Sell |
3,728
-219
| -6% | -$29.8K | 0.35% | 101 |
|
2020
Q1 | $427K | Buy |
3,947
+15
| +0.4% | +$1.62K | 0.42% | 87 |
|
2019
Q4 | $474K | Buy |
+3,932
| New | +$474K | 0.4% | 83 |
|